Instead of being killed by antibiotics, these bacteria have evolved the ability to survive and thrive in their presence. Antibiotic resistant infections are challenging due to limited treatment options. The World Health Organization deems these infections one of the top 10 global public health threats facing humanity.
Learn about our platform and our first clinical prototype. This is Felix's phage-based therapy that's already been effective in treating Pseudomonas aeruginosa infections in cystic fibrosis
Felix PlatformWhen bacteria are exposed to antibiotics, they can acquire new features that help them to survive in the face of those antibiotics. An effective therapeutic alternative to antibiotics needs to target these resistance-conferring features.
Phages are highly selective and thus can be targeted to only kill bad bacteria — leaving the good bacteria alone. This precision is at the core of Felix’s phage engineering platform, which is able to harness the power of a phage with the accuracy of a sniper rifle.
Our platform makes it possible to program phage to outsmart bacterial evolution. We harness machine learning to design phage characteristics targeting the specific features that contribute to their lethality. This makes our phages an ‘intelligent’ tool to combat emergent antimicrobial resistance.
We’re building a technical team of scientists and engineers who are passionate about working on world-saving problems.
Careers